Clinical Trial Update: Toripalimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating toripalimab with concurrent chemoradiotherapy for cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Cervical Cancer | Phase 2 | Status: UNKNOWN